Report from the Annual General meeting of IRLAB Therapeutics AB

GOTHENBURG, SE / ACCESSWIRE / June 20, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Today, on Tuesday June 20, 2023, IRLAB Therapeutics AB held its Annual General Meeting at Wallenbergs Konferenscentrum, Medicinaregatan 20 A in Gothenburg, Sweden. Attorney Dag Fredlund from MAQS Advokatbyrå was elected as Chair of the Annual General Meeting. The following main resolutions were resolved upon at the Annual General Meeting.

Adoption of income statement and balance sheet as well as consolidated income statement and consolidated balance sheet

The Annual General Meeting adopted the income statement and the consolidated income statement as well as the balance sheet and the consolidated balance sheet for the financial year 2022.

Disposition of the company's results

The disposition of the company's results proposed by the board of directors was adopted by the Annual General Meeting. This means that the funds available to the Annual General Meeting, totaling SEK 441,879,993 shall be carried forward in full and that no dividend shall be paid for the past financial year.

Resolution on discharge of liability

The Annual General Meeting resolved on discharge of liability for all members of the board of directors and the managing director for the financial year 2022.

Election of Board members and auditor

The Annual General Meeting resolved that the board of directors shall consist of seven board members. Carola Lemne, Catharina Gustafsson Wallich, Gunnar Olsson and Rein Piir were re-elected as board members and Christer Nordstedt, Daniel Johnsson and Veronica Wallin were elected as new board members. Carola Lemne was re-elected as Chair of the board of directors for the period until the close of the next annual general meeting.

The Annual General Meeting resolved to re-elect Öhrlings PricewaterhouseCoopers AB (PwC) as auditor for the period until the close of the next annual general meeting with the authorised public accountant Ulrika Ramsvik as new auditor in charge.

A presentation of the newly elected board members, including an assessment of their independence in relation to the company, the company's management, and major shareholders, is available on the company's website (www.irlab.se).

Remuneration of the board of directors and the auditor

The Annual General Meeting resolved on remuneration to the board of directors with SEK 550,000 to the Chair of the board of directors and SEK 250,000 to each of the other board members. No director's fee shall however be paid if and during the time the board member is employed by the company or any of its subsidiaries.